Molecular classification of cancers of unknown primary expands and refines treatment options

被引：1

作者：

George, D. J. ^{[1
]}

Moore, E. ^{[2
]}

Blobe, G. C. ^{[3
]}

DeVito, N. ^{[4
]}

Hanks, B. A. ^{[5
]}

Harrison, M. R. ^{[6
]}

Hoimes, C. J. ^{[7
]}

Jia, J. ^{[8
]}

Morse, M. ^{[8
]}

Jayaprakasan, P. ^{[9
]}

MacKelfresh, A. ^{[10
]}

Mulder, H. ^{[11
]}

Beauchamp, K. ^{[12
]}

Michuda, J. ^{[13
]}

Stumpe, M. C. ^{[14
]}

Perakslis, E. ^{[15
]}

Taxter, T. ^{[16
]}

机构：

[1] Duke Univ, Med Ctr, Dept Med Oncol, Durham, NC USA

[2] Tempus Labs Inc, Algorithms, Chicago, IL USA

[3] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Duke Canc Inst, Durham, NC USA

[4] Duke Univ, LSRC c207, 308 Res Dr, Durham, NC USA

[5] Duke Univ, Med Ctr, Duke Canc Ctr, Med, Durham, NC USA

[6] Dept Med Oncol, Snyderman Genome Sci Res Bldg, Durham, NC USA

[7] Duke Canc Inst, Med Genitourinary Oncol, Durham, NC USA

[8] Duke Canc Ctr, Med Oncol, Durham, NC USA

[9] Duke Clin Res Inst, Technol & Data Solut, Durham, NC USA

[10] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA

[11] Duke Clin Res Inst, Ctr Predict Med, Durham, NC USA

[12] Tempus Labs Inc, Chicago, IL USA

[13] Tempus Labs Inc, Translat Res, Chicago, IL USA

[14] Tempus Labs, AI & Data Sci, Chicago, IL USA

[15] Duke Clin Res Inst, Durham, NC USA

[16] Tempus Labs, Chicago, IL USA

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.1048

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

923P

引用

页码：S968 / S969

页数：2

共 50 条

[1] Molecular Classification of Cancers of Unknown Primary Site
Greco, F. Anthony
Erlander, Mark G.
[J]. MOLECULAR DIAGNOSIS & THERAPY, 2009, 13 (06) : 367 - 373
[2] Molecular Classification of Cancers of Unknown Primary Site
F. Anthony Greco
Mark G. Erlander
[J]. Molecular Diagnosis & Therapy, 2009, 13 : 367 - 373
[3] Assessing the utility of molecular diagnostic classification for cancers of unknown primary
Moore, Elle C.
Blobe, Gerard C.
Devito, Nicholas C.
Hanks, Brent A.
Harrison, Michael R.
Hoimes, Christopher J.
Jia, Jingquan
Morse, Michael A.
Jayaprakasan, Parvathy
MacKelfresh, Andrew
Mulder, Hillary
Hockenberry, Adam J.
Zander, Alia
Stumpe, Martin C.
Michuda, Jackson
Beauchamp, Kyle A.
Perakslis, Eric
Taxter, Timothy
George, Daniel J.
[J]. CANCER MEDICINE, 2023, 12 (19): : 19394 - 19405
[4] Molecular Classification of Unknown Primary Cancer
Bender, Richard A.
Erlander, Mark G.
[J]. SEMINARS IN ONCOLOGY, 2009, 36 (01) : 38 - 43
[5] Research refines alcoholism treatment options
不详
[J]. ALCOHOL RESEARCH & HEALTH, 2000, 24 (01) : 53 - 61
[6] Diagnosis and treatment for rare cancers of unknown primary
Noguchi, Emi
[J]. ANNALS OF ONCOLOGY, 2022, 33 : S421 - S421
[7] Cancers of unknown primary
Tay, Jessica
Dewdney, Alice
[J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (05) : C70 - C74
[8] A Primary Approach to Cancers of Unknown Primary
Schwartz, Arnold M.
Harpaz, Noam
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (11) : 759 - 761
[9] A model for accurate histopathologic assessment refines treatment options
Sugarbaker, Paul H.
Van der Speeten, Kurt
[J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 : S230 - S230
[10] Romiplostim expands the Treatment Options for ITP
不详
[J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2012, 39 (06) : 423 - 423

← 1 2 3 4 5 →